As of August 2024, Excelsior Biopharma has a market cap of $45.77M. This makes Excelsior Biopharma the world's 25826th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $41.42M | -2.77% |
2023 | $42.60M | 3.78% |
2022 | $41.05M | -4.96% |
2021 | $43.19M | -1.35% |
2020 | $43.78M | -16.95% |
2019 | $52.71M | -12.18% |
2018 | $60.02M | -44.99% |
2017 | $109.12M | 17.30% |
2016 | $93.02M | -53.68% |
2015 | $200.81M | 119.35% |
2014 | $91.55M | - |